ArticleVaccine2023

Evaluation of transmission-blocking potential of Pv22 using clinical Plasmodium vivax infections and transgenic Plasmodium berghei.

Jie Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.